Table of Contents 1 Mantle Cell Lymphoma Treatment Market Overview 1.1 Mantle Cell Lymphoma Treatment Product Overview 1.2 Mantle Cell Lymphoma Treatment Market Segment by Type 1.2.1 Acalabrutinib 1.2.2 JCAR-017 1.2.3 JNJ-64052781 1.2.4 Acalisib 1.2.5 IGN-002 1.2.6 IMGN-529 1.2.7 AFM-11 1.2.8 Others 1.3 Global Mantle Cell Lymphoma Treatment Market Size by Type 1.3.1 Global Mantle Cell Lymphoma Treatment Sales and Growth by Type 1.3.2 Global Mantle Cell Lymphoma Treatment Sales and Market Share by Type (2014-2019) 1.3.3 Global Mantle Cell Lymphoma Treatment Revenue and Market Share by Type (2014-2019) 1.3.4 Global Mantle Cell Lymphoma Treatment Price by Type (2014-2019) 2 Global Mantle Cell Lymphoma Treatment Market Competition by Company 2.1 Global Mantle Cell Lymphoma Treatment Sales and Market Share by Company (2014-2019) 2.2 Global Mantle Cell Lymphoma Treatment Revenue and Share by Company (2014-2019) 2.3 Global Mantle Cell Lymphoma Treatment Price by Company (2014-2019) 2.4 Global Top Players Mantle Cell Lymphoma Treatment Manufacturing Base Distribution, Sales Area, Product Types 2.5 Mantle Cell Lymphoma Treatment Market Competitive Situation and Trends 2.5.1 Mantle Cell Lymphoma Treatment Market Concentration Rate 2.5.2 Global Mantle Cell Lymphoma Treatment Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Mantle Cell Lymphoma Treatment Company Profiles and Sales Data 3.1 Astex Pharmaceuticals, Inc. 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Bayer AG 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.2.3 Bayer AG Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Bristol-Myers Squibb Company 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Celgene Corporation 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Cellular Biomedicine Group, Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Eisai 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.6.3 Eisai Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 EpiZyme, Inc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 Fate Therapeutics, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 Genentech, Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Gilead Sciences, Inc. 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification 3.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 GlaxoSmithKline Plc 3.12 Hutchison MediPharma Limited 3.13 ImmunoGen, Inc. 3.14 Immunomedics, Inc. 4 Mantle Cell Lymphoma Treatment Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Mantle Cell Lymphoma Treatment Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Mantle Cell Lymphoma Treatment Sales and Revenue by Regions 4.2.1 Global Mantle Cell Lymphoma Treatment Sales and Market Share by Regions (2014-2019) 4.2.2 Global Mantle Cell Lymphoma Treatment Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Mantle Cell Lymphoma Treatment Application/End Users 5.1 Mantle Cell Lymphoma Treatment Segment by Application 5.1.1 Hospital 5.1.2 Clinic 5.1.3 Others 5.2 Global Mantle Cell Lymphoma Treatment Product Segment by Application 5.2.1 Global Mantle Cell Lymphoma Treatment Sales by Application 5.2.2 Global Mantle Cell Lymphoma Treatment Sales and Market Share by Application (2014-2019) 6 Global Mantle Cell Lymphoma Treatment Market Forecast 6.1 Global Mantle Cell Lymphoma Treatment Sales, Revenue Forecast (2019-2025) 6.1.1 Global Mantle Cell Lymphoma Treatment Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Mantle Cell Lymphoma Treatment Forecast by Regions 6.2.1 North America Mantle Cell Lymphoma Treatment Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Mantle Cell Lymphoma Treatment Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Mantle Cell Lymphoma Treatment Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Mantle Cell Lymphoma Treatment Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Mantle Cell Lymphoma Treatment Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Mantle Cell Lymphoma Treatment Forecast by Type 6.3.1 Global Mantle Cell Lymphoma Treatment Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Acalabrutinib Gowth Forecast 6.3.3 JCAR-017 Gowth Forecast 6.4 Mantle Cell Lymphoma Treatment Forecast by Application 6.4.1 Global Mantle Cell Lymphoma Treatment Sales Forecast by Application (2019-2025) 6.4.2 Global Mantle Cell Lymphoma Treatment Forecast in Hospital 6.4.3 Global Mantle Cell Lymphoma Treatment Forecast in Clinic 7 Mantle Cell Lymphoma Treatment Upstream Raw Materials 7.1 Mantle Cell Lymphoma Treatment Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Mantle Cell Lymphoma Treatment Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Mantle Cell Lymphoma Treatment Product Picture Figure Global Mantle Cell Lymphoma Treatment Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Status and Outlook (2014-2025) Figure Product Picture of Acalabrutinib Table Major Players of Acalabrutinib Figure Global Acalabrutinib Sales (K Pcs) and Growth Rate (%)(2014-2018) Figure Product Picture of JCAR-017 Table Major Players of JCAR-017 Figure Global JCAR-017 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of JNJ-64052781 Table Major Players of JNJ-64052781 Figure Global JNJ-64052781 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Acalisib Table Major Players of Acalisib Figure Global Acalisib Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of IGN-002 Table Major Players of IGN-002 Figure Global IGN-002 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of IMGN-529 Table Major Players of IMGN-529 Figure Global IMGN-529 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of AFM-11 Table Major Players of AFM-11 Figure Global AFM-11 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (K Pcs) and Growth Rate (%)(2014-2019) Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) by Type (2014-2019) Table Global Mantle Cell Lymphoma Treatment Sales Share (%) by Type (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Type (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Type in 2018 Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) by Type (2014-2019) Table Global Mantle Cell Lymphoma Treatment Revenue Share (%) by Type (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Revenue Share (%) by Type (2014-2019) Figure 2018 Global Mantle Cell Lymphoma Treatment Revenue Market Share (%) by Type Table Global Mantle Cell Lymphoma Treatment Price (USD/Pcs) by Type (2014-2019) Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) by Company (2014-2019) Table Global Mantle Cell Lymphoma Treatment Sales Share (%) by Company (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Sales Share (%) by Company in 2018 Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) by Company (2014-2019) Table Global Mantle Cell Lymphoma Treatment Revenue Share (%) by Company (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Revenue Share (%) by Company in 2018 Table Global Market Mantle Cell Lymphoma Treatment Average Price (USD/Pcs) by Company (2014-2019) Table Global Mantle Cell Lymphoma Treatment Top Players Manufacturing Base Distribution and Sales Area Table Global Mantle Cell Lymphoma Treatment Top Players Product Category Figure Global Mantle Cell Lymphoma Treatment Market Share (%) of Top 5 Players Figure Global Mantle Cell Lymphoma Treatment Market Share (%) of Top 10 Players Table Astex Pharmaceuticals, Inc. Basic Information List Table Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Bayer AG Basic Information List Figure Bayer AG Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Bayer AG Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Bayer AG Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Bayer AG Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Bristol-Myers Squibb Company Basic Information List Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Celgene Corporation Basic Information List Figure Celgene Corporation Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Celgene Corporation Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Celgene Corporation Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Celgene Corporation Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Cellular Biomedicine Group, Inc. Basic Information List Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Eisai Basic Information List Figure Eisai Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Eisai Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Eisai Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Eisai Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table EpiZyme, Inc. Basic Information List Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Fate Therapeutics, Inc. Basic Information List Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Genentech, Inc. Basic Information List Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Genentech, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table Gilead Sciences, Inc. Basic Information List Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product Category, Application and Specification Table Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales Growth Rate (2014-2019) Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales Global Market Share (%)(2014-2019) Table GlaxoSmithKline Plc Basic Information List Table Hutchison MediPharma Limited Basic Information List Table ImmunoGen, Inc. Basic Information List Table Immunomedics, Inc. Basic Information List Table Global Mantle Cell Lymphoma Treatment Market Size Comparison by Regions (2014-2025) Figure North America Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) by Regions (2014-2019) Table Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Regions (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Regions Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Mantle Cell Lymphoma Treatment Revenue Market Share (%) by Regions (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Mantle Cell Lymphoma Treatment Revenue Market Share (%) by Regions Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North America Mantle Cell Lymphoma Treatment Sales Growth Rate Table North America Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure United States Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure United States Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Canada Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Canada Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Mexico Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Mexico Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Europe Mantle Cell Lymphoma Treatment Sales Growth Rate Table Europe Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Germany Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Germany Mantle Cell Lymphoma Treatment Revenue (Million USD) (2014-2019) Figure UK Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure UK Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure France Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure France Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Italy Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Italy Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Russia Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Russia Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Turkey Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Turkey Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Asia-Pacific Mantle Cell Lymphoma Treatment Sales Growth Rate Table Asia-Pacific Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure China Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure China Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Japan Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Japan Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Korea Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Korea Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Southeast Asia Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Indonesia Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Indonesia Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Thailand Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Thailand Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Malaysia Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Malaysia Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Philippines Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Philippines Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Vietnam Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Vietnam Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure India Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure India Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Australia Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Australia Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure South America Mantle Cell Lymphoma Treatment Sales Growth Rate Table South America Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Brazil Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure Brazil Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Middle East and Africa Mantle Cell Lymphoma Treatment Sales Growth Rate Table Middle East and Africa Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North Africa Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure North Africa Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure GCC Countries Mantle Cell Lymphoma Treatment Sales (K Pcs)(2014-2019) Figure GCC Countries Mantle Cell Lymphoma Treatment Revenue (Million USD)(2014-2019) Figure Hospital Examples Figure Clinic Examples Figure Others Examples Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Comparison by Application (2014-2025) Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) by Application (2014-2019) Table Global Mantle Cell Lymphoma Treatment Sales Share (%) by Application (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Application (2014-2019) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) by Application in 2018 Figure Global Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Global Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Regions (2019-2025) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North America Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Europe Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure China Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Japan Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Korea Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure India Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Australia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure South America Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Mantle Cell Lymphoma Treatment Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Mantle Cell Lymphoma Treatment Sales (Million USD) Forecast by Type (2019-2025) Figure Global Mantle Cell Lymphoma Treatment Sales Market Share (%) Forecast by Type (2019-2025) Table Global Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Mantle Cell Lymphoma Treatment Revenue Market Share (%) Forecast by Type (2019-2025) Figure Acalabrutinib Sales Growth Forecast Figure JCAR-017 Sales Growth Forecast Table Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Application (2019-2025) Figure Global Mantle Cell Lymphoma Treatment Sales Forecast by Application (2019-2025) Figure Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast in Hospital Figure Global Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast in Clinic Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Mantle Cell Lymphoma Treatment Manufacturing Cost Structure Figure Mantle Cell Lymphoma Treatment Industrial Chain Analysis Table Distributors List Table Mantle Cell Lymphoma Treatment Downstream Customers

Astex Pharmaceuticals, Inc. Bayer AG Bristol-Myers Squibb Company Celgene Corporation Cellular Biomedicine Group, Inc. Eisai EpiZyme, Inc. Fate Therapeutics, Inc. Genentech, Inc. Gilead Sciences, Inc. GlaxoSmithKline Plc Hutchison MediPharma Limited ImmunoGen, Inc. Immunomedics, Inc.